While this animal model of atherosclerosis is heavily driven by circulating LDL on high fat high cholesterol diet because of the absence of LDL receptor, nevertheless, we attempted to investigate the RCT component in the inhibition of atherosclerosis progression following treatment with LXR and PPAR-α agonists. This evidence concerns the gene LDLR and atherosclerosis.